Free Trial
Notice: An IPO for ZYBT is planned for Monday, December 23, 2024

Zhengye Biotechnology (ZYBT) Competitors

ZYBT vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Zhengye Biotechnology stock or one of its competitors? The main competitors of Zhengye Biotechnology include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Zhengye Biotechnology vs.

180 Life Sciences (NASDAQ:ATNFW) and Zhengye Biotechnology (NASDAQ:ZYBT) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

180 Life Sciences and Zhengye Biotechnology both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Zhengye BiotechnologyN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Zhengye Biotechnology N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Zhengye Biotechnology'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Zhengye Biotechnology Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Zhengye BiotechnologyN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Zhengye Biotechnology tied by winning 0 of the 0 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZYBT vs. The Competition

MetricZhengye BiotechnologyPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$6.57B$2.17B$9.08B
Dividend YieldN/A2.99%2.72%4.23%
P/E RatioN/A10.5927.6417.18
Price / SalesN/A196.06167.93117.05
Price / CashN/A57.16N/A37.85
Price / BookN/A5.091.944.78
Net IncomeN/A$151.83M$257.43M$225.60M

Zhengye Biotechnology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZYBT
Zhengye Biotechnology
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+31.6%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
flat
N/A+22.1%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/A-89.6%$0.00$40,633.000.0040News Coverage
Gap Up
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+48.5%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.6676 of 5 stars
$12.05
+2.1%
$18.00
+49.4%
+6.9%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A+408.0%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
flat
N/A+340.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/A-56.1%$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:ZYBT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners